This disclosure generally relates to minimally invasive heart surgery, also known as percutaneous cardiac surgery and particularly relates to percutaneous mapping and ablation.
Atrial fibrillation is a well known disorder in which spurious electrical signals cause an irregular heart beat. The disorder has a well known cure known as the Maze procedure, in which a border is ablated around the sources of the spurious signals, typically in the left atrium but sometimes in the right atrium. The procedure is very commonly performed under direct vision, but difficult to perform percutaneously via a catheter because of the associated risk. Any error in navigation inside the heart can cause fatal damage. The key to a percutaneous procedure is mapping of the inside of the right and left atrium. Access to the right atrium is simple via the superior vena cava; the left atrium can be reached i) by perforating the transatrial septum, ii) via the aorta and the left ventricle or iii) via the pulmonary veins.
Prior approaches to map the inside of the atrium relied on electrical activity picked up from the atrium wall. These approaches require intimate electrical contact, not always possible because of scar tissue and deposits. These approaches may fail to accurately map the edges of the openings where the veins enter the atrium; information that is useful for correct placement of the ablation pattern. Other mapping methods, such as using an array of ultrasonic transducers, are not practical since such arrays typically will not fit through a catheter of a reasonable size (8-10 mm diameter). A superior mapping apparatus and method, that enables safe execution of the Maze and other intra-cardiac procedures is desirable.
A good survey article on the subject is: “Ablation of Atrial Fibrillation: Energy Sources and Navigation Tools: A survey” by Ruediger Becker and Wolfgang Schoels (J. of Electrocardiology, Vol 37, 2004, pp 55-61). The article includes an extensive bibliography.
Embodiments of an intra-cardiac mapping system are based on locating openings or ports and values through which blood flows in or out of the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, accurately locating the pulmonary veins and the mitral valve allows performance of a Maze procedure. The openings, ports and valves may be located based on the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
In one embodiment, a method for intra-cardiac mapping comprises: introducing a plurality of flow sensors into an intra-cardiac cavity: locating points in a wall forming said cavity based on sensing blood flow; and mapping said walls of said cavity based on said points. The method for intra-cardiac mapping may include said blood flow being sensed by its convective cooling effect on a heated sensor. The method for intra-cardiac mapping may include said sensing being done by a steerable linear array. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by RF ablation. The method for intra-cardiac mapping may include being used for treating atrial fibrillation by microwave ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by cryogenic ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by laser ablation. The method for intra-cardiac mapping may include said blood flow being sensed by the resistance change of a heated resistive wire.
In another embodiment, a method for intra-cardiac mapping comprises: introducing an expandable sensing mesh into said cavity via a catheter; using said mesh to locate openings in walls forming said cavity based on the convective heat transfer of blood flowing through said holes; and mapping inside of said cavity based on location of said openings. The method for intra-cardiac mapping may include said blood flow being sensed by its convective cooling effect on a heated sensor. The method for intra-cardiac mapping may include said sensing being done by a steerable linear array. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by RF ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by microwave ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by cryogenic ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by laser ablation. The method for intra-cardiac mapping may include said blood flow being sensed by the resistance change of a heated resistive wire. The method for intra-cardiac mapping may include said mesh comprising small coils of nickel wire wound on a mesh of a flexible insulator. The method for intra-cardiac mapping may include an electronic switch used to minimize the number of electrical wires passing through said catheter.
In yet another embodiment, a method for treating atrial fibrillation comprises: introducing at least one flow sensor into an intra-cardiac cavity; locating points in a wall forming said cavity based on sensing blood flow; mapping walls of said cavity based on said points; and ablating a pattern into walls of said cavity based on said mapping. The method for treating atrial fibrillation may include said blood flow being sensed by its convective cooling effect on a heated sensor. The method for treating atrial fibrillation may include said sensing being done by a steerable linear array. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by RF ablation. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by microwave ablation. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by cryogenic ablation. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by laser ablation. The method for treating atrial fibrillation may include said blood flow being sensed by the resistance change of a heated resistive wire. The method for treating atrial fibrillation may include said flow sensors also acting as electrodes for said ablation. The method for treating atrial fibrillation may include said flow sensor being based on temperature sensing and a same sensor being used to monitor temperature during said ablation. The method for treating atrial fibrillation may include said ablation being unipolar. The method for treating atrial fibrillation may include said ablation being bipolar. The method for treating atrial fibrillation may include said ablated pattern being a Maze procedure.
In the drawings, identical reference numbers identify similar elements or acts. It is to be understood that the attached drawings are for purposes of illustrating the concepts of the invention and may not be to scale. For example, the sizes, relative positions, shapes, and angles of or associated with elements in the drawings are not necessarily drawn to scale, and some elements may be arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn may differ from their actual shapes and, in this regard, may be selected instead of the respective actual shapes for ease of recognition in the drawings.
In the following description, certain specific details are set forth in order to provide a thorough understanding of various disclosed embodiments. However, one skilled in the relevant art will recognize that embodiments may be practiced without one or more of these specific details, or with other methods, components, materials, etc. In other instances, well-known structures associated with apparatuses and methods for intra-cardiac mapping and ablation have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments.
Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense, that is as “including, but not limited to.”
Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its non-exclusive sense including “and/or” unless the content clearly dictates otherwise.
The headings and Abstract of the Disclosure provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
By way of example, the mesh 7 may be delivered via a catheter 60 inserted via a superior vena cava 4 and penetrating a transatrial septum from a right atrium 2 of the heart 1. The mesh 7 is communicatively coupled to the rest of the system, for example, by electrical wires 6.
Before any ablation takes place, the inside of the left atrium 3 is mapped in order to locate the openings or ports 8 leading to the pulmonary veins 5, as well as the mitral valve 9. A typical Maze procedure ablates a “fence” around openings or ports 8 to stop propagation of spurious electrical signals which cause the heart 1 to contract at the wrong times.
The mapping may locate some or all of the openings or ports 8 through which blood flows in and out of the left atrium 3, as the Maze procedure is mainly concerned with the location of these openings or ports 8. By the way of example, in the left atrium 3, the four openings or ports 8 leading to the pulmonary veins 5 as well as the mitral valve 9 may be located. The location of these openings or ports 8 may be based on the fact that the convective cooling effect of the blood is significant, and a slightly heated mesh 7 pressed against the walls of the left and/or right atrium 3, 2 will be cooler at the areas which are spanning the openings or ports 8 carrying blood.
By identifying the relatively cooler elements 10a, 10c on the mesh 7, the location of the openings or ports 8 may be found.
This method does not require intimate contact with the wall 3, as the cooling effect is significant even a few millimeters away from the opening.
The same elements 10 can be used as ablation electrodes during an ablation stage. It was found that the power required to raise the temperature of the mesh 7 by a small but easily detectable amount is very small, on the order of 10-50 mW per element 10. If the elements 10 are made of a material that has a significant change in resistance with temperature, the temperature drop can be sensed by measuring a voltage across the element 10 when driven by a constant current. A good choice for element material is nickel wire, which is inert, highly resistive and has a significant temperature coefficient of resistance (about 0.6% per deg C.). Since the resistance of the elements 10 is low (typically 0.1-1 ohm), the electrical noise is very low and temperature changes as low as 0.1 deg can be easily detected. For even higher detection sensitivity, the voltage waveform can be sampled in sychronization with the heart rate or the average voltage removed and only the change amplified. Such methods are referred to as “AC coupling”. A further refinement to reduce the electrical noise is to pass the signal through a digital band pass filter having a center frequency tracking the heart rate. To avoid any potential tissue damage, the temperature of the elements 10 of the mesh 7 is only slightly above the blood temperature, typically 0.1-3 degrees C. above blood temperature.
The mode selection 17 selects between a mapping mode (position shown in the drawing) and an ablation mode (second position of switch). In the mapping mode, a current is created by a voltage source 18 and resistor 19 (e.g., forming a constant current source) and routed into a selected element 10 by the element switches 15. For each measurement, the two element switches 15 that are connected to the scanned element 10 are in an enabled state (ON), the rest of the element switches being in a disabled state (OFF). The voltage drop across an element 10 is measured by an analog to digital (A/D) converter 20 and fed to a control computer 23. For greater accuracy, four terminal sensing can be employed. In a preferred embodiment, the detection is AC coupled, therefore the DC voltage drops along the wires are of no consequence, and no four-terminal sensing is needed. For AC coupling, the control computer 23 may include a 0.5 Hz low pass filter, which may be implemented in software. The slight disadvantage of the AC coupled method approach is speed, as the low signal frequency (e.g., about 1 Hz), requires a few seconds per measurement. Other temperature sensors and/or approaches, such as thermistors or thermocouples, can be used in conjunction with the elements 10. Mapping is achieved by turning on all of the elements 10 (e.g., sequentially) and measuring the temperature of each. A map may be formed in the control computer 23 and the lower temperature spots on the mesh correspond to the openings or ports 8 leading to the veins or valves.
When the mode selection switch 17 is in the ablation mode, a generator 21 (e.g., Radio Frequency (RF)) is connected (e.g., sequentially) to selected elements 10 by the control computer 23 addressing the multiplexer 22 which controls the element switches 15 via the de-multiplex selector 16. The complete operation, including scanning and ablation, can be completed in less than 5 minutes. The configuration illustrated in
During ablation it is desirable to monitor the temperature of the mode selection switch 17 to the mapping position several times during the ablation procedure. The measured temperatures can be displayed on a display 32 (
After a map is established, it is displayed on a display screen 32 as shown in
An alternative to a full mesh is a partial mesh, or even a single sensor, that is mechanically scanned across the area to be mapped.
A full mesh trades a higher complexity for better speed and accuracy when compared to linear arrays or single point scanning.
The previous examples were of unipolar ablation, with the ablation current returning to ground via the patient's body. The disclosed system can also be used for bipolar ablation as shown in
One possible advantage of at least some of the presently disclosed embodiments over electrical potential mapping methods is that the presently disclosed embodiments do not require perfect contact between the mesh 7 and the tissue 1. The presently disclosed embodiments may also advantageously be less sensitive to the surface properties of the tissue, such as scar tissue or plaque.
If the mesh is separated from the tissue by a thin layer of blood, both the temperature sensing and the ablation functions of the presently disclosed embodiments will still function properly.
The word “element” in this disclosure has to be interpreted in a broad sense as any element capable of sensing blood flow. Clearly the elements do not need to be heaters, as cooling elements will work equally well. If a material is injected into the blood flow, any sensor capable of detecting this material can be used to detect blood flow. By the way of example, if the blood is cooled or warmed slightly before returning to the heart only temperatures sensors are needed. Since temperature differences as low as 0.1 degree C. can be detected reliably, it is fairly simple to heat or cool the blood slightly before it returns to the heart (even by a simple external pad).
The above description of illustrated embodiments, including what is described in the Abstract, is not intended to be exhaustive or to limit the embodiments to the precise forms disclosed. Although specific embodiments of and examples are described herein for illustrative purposes, various equivalent modifications can be made without departing from the spirit and scope of the disclosure, as will be recognized by those skilled in the relevant art.
The various embodiments described above can be combined to provide further embodiments. All of the U.S. patents. U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet are incorporated herein by reference, in their entirety. Aspects of the embodiments can be modified, if necessary, to employ systems, circuits and concepts of the various patents, applications and publications to provide yet further embodiments.
These and other changes can be made to the embodiments in light of the above-detailed description. In general. in the following claims, the terms used should not be construed to limit the claims to the specific embodiments disclosed in the specification and the claims, but should be construed to include all possible embodiments along with the full scope of equivalents to which such claims are entitled. Accordingly, the claims are not limited by the disclosure.
This application is a continuation of prior U.S. patent application Ser. No. 15/697,744, filed Sep. 7, 2017, now U.S. Pat. No. 10,828,093, issued on Nov. 10, 2020, which is a continuation of prior U.S. patent application Ser. No. 14/804,810, filed Jul. 21, 2015, now U.S. Pat. No. 9,987,083 issued on Jun. 5, 2018, which is a continuation of prior U.S. patent application Ser. No. 13/785,931, filed Mar. 5, 2013, now U.S. Pat. No. 9,119,633, issued on Sep. 1, 2015, which is a continuation-in-part of prior U.S. patent application Ser. No. 11/475,950, filed Jun. 28, 2006, now U.S. Pat. No. 8,920,411, issued on Dec. 30, 2014, the entire disclosure of each of these applications is hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4114202 | Roy et al. | Sep 1978 | A |
4164046 | Cooley | Aug 1979 | A |
4225148 | Andersson | Sep 1980 | A |
4240441 | Khalil | Dec 1980 | A |
4263680 | Reul et al. | Apr 1981 | A |
4273128 | Lary | Jun 1981 | A |
4411266 | Cosman | Oct 1983 | A |
4490859 | Black et al. | Jan 1985 | A |
4543090 | McCoy | Sep 1985 | A |
4576182 | Normann | Mar 1986 | A |
4699147 | Chilson et al. | Oct 1987 | A |
4770187 | Lash et al. | Sep 1988 | A |
4787369 | Allred, III et al. | Nov 1988 | A |
4794912 | Lia | Jan 1989 | A |
4850957 | Summers | Jul 1989 | A |
4887613 | Farr et al. | Dec 1989 | A |
4890602 | Hake | Jan 1990 | A |
4890612 | Kensey | Jan 1990 | A |
4893613 | Hake | Jan 1990 | A |
4895166 | Farr et al. | Jan 1990 | A |
4905667 | Foerster et al. | Mar 1990 | A |
4921499 | Hoffman et al. | May 1990 | A |
4940064 | Desai | Jul 1990 | A |
4942788 | Farr et al. | Jul 1990 | A |
4979514 | Seku et al. | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5047047 | Yoon | Sep 1991 | A |
5122137 | Lennox | Jun 1992 | A |
5127902 | Fischell | Jul 1992 | A |
5153151 | Aitken | Oct 1992 | A |
5156151 | Imran | Oct 1992 | A |
5174299 | Nelson | Dec 1992 | A |
5176693 | Pannek, Jr. | Jan 1993 | A |
5178620 | Eggers et al. | Jan 1993 | A |
5192291 | Pannek, Jr. | Mar 1993 | A |
5195505 | Josefsen | Mar 1993 | A |
5201316 | Pomeranz et al. | Apr 1993 | A |
5228442 | Imran | Jul 1993 | A |
5242386 | Holzer | Sep 1993 | A |
5245987 | Redmond et al. | Sep 1993 | A |
5255679 | Imran | Oct 1993 | A |
5279299 | Imran | Jan 1994 | A |
5293869 | Edwards et al. | Mar 1994 | A |
5297549 | Beatty et al. | Mar 1994 | A |
5309910 | Edwards et al. | May 1994 | A |
5311866 | Kagan | May 1994 | A |
5312435 | Nash et al. | May 1994 | A |
5317952 | Immega | Jun 1994 | A |
5324284 | Imran | Jun 1994 | A |
5327889 | Imran | Jul 1994 | A |
5341807 | Nardella | Aug 1994 | A |
5345936 | Pomeranz et al. | Sep 1994 | A |
5351551 | Drubetsky | Oct 1994 | A |
5351679 | Mayzels et al. | Oct 1994 | A |
5366443 | Eggers et al. | Nov 1994 | A |
5370679 | Atlee, III | Dec 1994 | A |
5379773 | Hornsby | Jan 1995 | A |
5397321 | Houser et al. | Mar 1995 | A |
5419767 | Eggers et al. | May 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5456254 | Pietroski et al. | Oct 1995 | A |
5462545 | Wang | Oct 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5485849 | Panescu et al. | Jan 1996 | A |
5496267 | Drasler et al. | Mar 1996 | A |
5496330 | Bates | Mar 1996 | A |
5499981 | Kordis | Mar 1996 | A |
5531760 | Alwafaie | Jul 1996 | A |
5545193 | Fleischman et al. | Aug 1996 | A |
5549661 | Kordis et al. | Aug 1996 | A |
5555883 | Avitall | Sep 1996 | A |
5557967 | Renger | Sep 1996 | A |
5575810 | Swanson et al. | Nov 1996 | A |
5593424 | Northrup, III | Jan 1997 | A |
5598848 | Swanson et al. | Feb 1997 | A |
5599345 | Edwards et al. | Feb 1997 | A |
5620481 | Desai et al. | Apr 1997 | A |
5630813 | Kieturakis | May 1997 | A |
5636634 | Kordis | Jun 1997 | A |
5637090 | McGee et al. | Jun 1997 | A |
5662587 | Grundfest et al. | Sep 1997 | A |
5681308 | Edwards et al. | Oct 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5687723 | Avitall | Nov 1997 | A |
5687737 | Branham et al. | Nov 1997 | A |
5697285 | Nappi et al. | Dec 1997 | A |
5704914 | Stocking | Jan 1998 | A |
5713896 | Nardella | Feb 1998 | A |
5713942 | Stern et al. | Feb 1998 | A |
5716397 | Myers | Feb 1998 | A |
5720726 | Marcadis et al. | Feb 1998 | A |
5728114 | Evans et al. | Mar 1998 | A |
5730127 | Avitall | Mar 1998 | A |
5738096 | Ben-Haim | Apr 1998 | A |
5762066 | Law et al. | Jun 1998 | A |
5769846 | Edwards et al. | Jun 1998 | A |
5782239 | Webster, Jr. | Jul 1998 | A |
5782879 | Rosborough et al. | Jul 1998 | A |
5800495 | Machek et al. | Sep 1998 | A |
5823189 | Kordis | Oct 1998 | A |
5824066 | Gross | Oct 1998 | A |
5831159 | Renger | Nov 1998 | A |
5836947 | Fleischman et al. | Nov 1998 | A |
5836990 | Li | Nov 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5868743 | Saul | Feb 1999 | A |
5868755 | Kanner et al. | Feb 1999 | A |
5876343 | Teo | Mar 1999 | A |
5879295 | Li et al. | Mar 1999 | A |
5881727 | Edwards | Mar 1999 | A |
5885278 | Fleischman | Mar 1999 | A |
5891136 | McGee et al. | Apr 1999 | A |
5893847 | Kordis | Apr 1999 | A |
5904711 | Flom et al. | May 1999 | A |
5916163 | Panescu et al. | Jun 1999 | A |
5919207 | Taheri | Jul 1999 | A |
5921924 | Avitall | Jul 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5935079 | Swanson et al. | Aug 1999 | A |
5941251 | Panescu et al. | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5961440 | Schweich, Jr. et al. | Oct 1999 | A |
5968040 | Swanson et al. | Oct 1999 | A |
5984950 | Cragg et al. | Nov 1999 | A |
6001069 | Tachibana et al. | Dec 1999 | A |
6001093 | Swanson et al. | Dec 1999 | A |
6014581 | Whayne et al. | Jan 2000 | A |
6023638 | Swanson | Feb 2000 | A |
6030382 | Fleischman et al. | Feb 2000 | A |
6036689 | Tu et al. | Mar 2000 | A |
6063082 | DeVore et al. | May 2000 | A |
6071282 | Fleischman | Jun 2000 | A |
6104944 | Martinelli | Aug 2000 | A |
6106460 | Panescu | Aug 2000 | A |
6106522 | Fleischman et al. | Aug 2000 | A |
6119030 | Morency | Sep 2000 | A |
6123702 | Swanson et al. | Sep 2000 | A |
6138043 | Avitall | Oct 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6156046 | Passafaro et al. | Dec 2000 | A |
6210432 | Solem et al. | Apr 2001 | B1 |
6216043 | Swanson et al. | Apr 2001 | B1 |
6217573 | Webster | Apr 2001 | B1 |
6240307 | Beatty | May 2001 | B1 |
6241747 | Ruff | Jun 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6248124 | Pedros et al. | Jun 2001 | B1 |
6254598 | Edwards | Jul 2001 | B1 |
6258258 | Sartori et al. | Jul 2001 | B1 |
6266550 | Selmon et al. | Jul 2001 | B1 |
6304769 | Arenson et al. | Oct 2001 | B1 |
6306135 | Ellman et al. | Oct 2001 | B1 |
6308091 | Avitall | Oct 2001 | B1 |
6319249 | Tollner | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6330478 | Lee et al. | Dec 2001 | B1 |
6346105 | Tu et al. | Feb 2002 | B1 |
6350263 | Wetzig et al. | Feb 2002 | B1 |
6358258 | Arcia et al. | Mar 2002 | B1 |
6383151 | Diederich et al. | May 2002 | B1 |
6389311 | Whayne et al. | May 2002 | B1 |
6391024 | Sun et al. | May 2002 | B1 |
6391048 | Ginn et al. | May 2002 | B1 |
6391054 | Carpentier et al. | May 2002 | B2 |
6402781 | Langberg et al. | Jun 2002 | B1 |
6428537 | Swanson | Aug 2002 | B1 |
6436052 | Nikolic et al. | Aug 2002 | B1 |
6475223 | Werp et al. | Nov 2002 | B1 |
6485409 | Voloshin et al. | Nov 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6485489 | Teirstein et al. | Nov 2002 | B2 |
6506210 | Kanner | Jan 2003 | B1 |
6514249 | Maguire et al. | Feb 2003 | B1 |
6517534 | McGovern | Feb 2003 | B1 |
6529756 | Phan et al. | Mar 2003 | B1 |
6537198 | Vidlund et al. | Mar 2003 | B1 |
6537314 | Langberg et al. | Mar 2003 | B2 |
6540670 | Hirata et al. | Apr 2003 | B1 |
6551310 | Ganz et al. | Apr 2003 | B1 |
6551312 | Zhang et al. | Apr 2003 | B2 |
6569160 | Goldin et al. | May 2003 | B1 |
6569198 | Wilson et al. | May 2003 | B1 |
6575971 | Hauck et al. | Jun 2003 | B2 |
6589208 | Ewers et al. | Jul 2003 | B2 |
6616684 | Vidlund et al. | Sep 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6632238 | Ginn et al. | Oct 2003 | B2 |
6635056 | Kadhiresan et al. | Oct 2003 | B2 |
6640119 | Budd et al. | Oct 2003 | B1 |
6652515 | Maguire et al. | Nov 2003 | B1 |
6652517 | Hall et al. | Nov 2003 | B1 |
6662034 | Segner et al. | Dec 2003 | B2 |
6666862 | Jain et al. | Dec 2003 | B2 |
D484979 | Fontaine | Jan 2004 | S |
6704590 | Haldeman | Mar 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6725085 | Schwartzman et al. | Apr 2004 | B2 |
6726716 | Marquez | Apr 2004 | B2 |
6733499 | Scheib | May 2004 | B2 |
6735465 | Panescu | May 2004 | B2 |
6760616 | Hoey et al. | Jul 2004 | B2 |
6780197 | Roe et al. | Aug 2004 | B2 |
6788969 | Dupree et al. | Sep 2004 | B2 |
6795721 | Coleman et al. | Sep 2004 | B2 |
6797001 | Mathis et al. | Sep 2004 | B2 |
6800090 | Alferness et al. | Oct 2004 | B2 |
6824562 | Mathis et al. | Nov 2004 | B2 |
6837886 | Collins et al. | Jan 2005 | B2 |
6852076 | Nikolic et al. | Feb 2005 | B2 |
6855143 | Davison et al. | Feb 2005 | B2 |
6890353 | Cohn et al. | May 2005 | B2 |
6892091 | Ben-Haim et al. | May 2005 | B1 |
6899674 | Viebach et al. | May 2005 | B2 |
6907297 | Wellman et al. | Jun 2005 | B2 |
6908478 | Alferness et al. | Jun 2005 | B2 |
6913576 | Bowman | Jul 2005 | B2 |
6918903 | Bass | Jul 2005 | B2 |
6926669 | Stewart et al. | Aug 2005 | B1 |
6936047 | Nasab et al. | Aug 2005 | B2 |
6942657 | Sinofsky et al. | Sep 2005 | B2 |
6949122 | Adams et al. | Sep 2005 | B2 |
6955640 | Sanders et al. | Oct 2005 | B2 |
6960206 | Keane | Nov 2005 | B2 |
6960229 | Mathis et al. | Nov 2005 | B2 |
6966908 | Maguire et al. | Nov 2005 | B2 |
6986775 | Morales et al. | Jan 2006 | B2 |
6989010 | Francischelli et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6994093 | Murphy et al. | Feb 2006 | B2 |
6997925 | Maguire et al. | Feb 2006 | B2 |
6997951 | Solem et al. | Feb 2006 | B2 |
7001383 | Keidar | Feb 2006 | B2 |
7003342 | Plaza | Feb 2006 | B2 |
7025776 | Houser et al. | Apr 2006 | B1 |
7044135 | Lesh | May 2006 | B2 |
7048734 | Fleischman et al. | May 2006 | B1 |
7050848 | Hoey et al. | May 2006 | B2 |
7052487 | Cohn et al. | May 2006 | B2 |
7068867 | Adoram et al. | Jun 2006 | B2 |
7141019 | Pearlman | Nov 2006 | B2 |
7144363 | Pai et al. | Dec 2006 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7174201 | Govari et al. | Feb 2007 | B2 |
7177677 | Kaula et al. | Feb 2007 | B2 |
7186210 | Feld et al. | Mar 2007 | B2 |
7187964 | Khoury | Mar 2007 | B2 |
7189202 | Lau et al. | Mar 2007 | B2 |
7194294 | Panescu et al. | Mar 2007 | B2 |
7198635 | Danek et al. | Apr 2007 | B2 |
7252664 | Nasab et al. | Aug 2007 | B2 |
7255695 | Falwell et al. | Aug 2007 | B2 |
7276044 | Ferry et al. | Oct 2007 | B2 |
7279007 | Nikolic et al. | Oct 2007 | B2 |
7282030 | Frei et al. | Oct 2007 | B2 |
7300435 | Wham et al. | Nov 2007 | B2 |
7303526 | Sharkey et al. | Dec 2007 | B2 |
7335196 | Swanson et al. | Feb 2008 | B2 |
7340307 | Maguire et al. | Mar 2008 | B2 |
7481808 | Koyfman et al. | Jan 2009 | B2 |
7507252 | Lashinski et al. | Mar 2009 | B2 |
7530980 | Hooven | May 2009 | B2 |
7575566 | Scheib | Aug 2009 | B2 |
7593760 | Rodriguez et al. | Sep 2009 | B2 |
7610078 | Willis | Oct 2009 | B2 |
7633502 | Willis et al. | Dec 2009 | B2 |
7660452 | Zwirn et al. | Feb 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7738967 | Salo | Jun 2010 | B2 |
8012149 | Jackson | Sep 2011 | B2 |
8103338 | Harlev et al. | Jan 2012 | B2 |
D654588 | Taube et al. | Feb 2012 | S |
8118853 | Grewe | Feb 2012 | B2 |
8150499 | Gelbart et al. | Apr 2012 | B2 |
D660967 | Braido et al. | May 2012 | S |
8200308 | Zhang et al. | Jun 2012 | B2 |
8216216 | Warnking et al. | Jul 2012 | B2 |
8221411 | Francischelli et al. | Jul 2012 | B2 |
8224432 | Macadam et al. | Jul 2012 | B2 |
8326419 | Rosenberg et al. | Dec 2012 | B2 |
8352019 | Starks | Jan 2013 | B2 |
8398631 | Ganz | Mar 2013 | B2 |
8401645 | Rosenberg et al. | Mar 2013 | B2 |
8414508 | Thapliyal et al. | Apr 2013 | B2 |
8442613 | Kim et al. | May 2013 | B2 |
8442625 | Markowitz et al. | May 2013 | B2 |
8457371 | Markowitz et al. | Jun 2013 | B2 |
8463368 | Harlev et al. | Jun 2013 | B2 |
8532734 | Markowitz et al. | Sep 2013 | B2 |
8562559 | Bishop | Oct 2013 | B2 |
8571647 | Harlev et al. | Oct 2013 | B2 |
8615287 | Harlev et al. | Dec 2013 | B2 |
8657814 | Werneth et al. | Feb 2014 | B2 |
8663120 | Markowitz et al. | Mar 2014 | B2 |
8706260 | Stewart et al. | Apr 2014 | B2 |
8725240 | Harlev et al. | May 2014 | B2 |
8831701 | Markowitz et al. | Sep 2014 | B2 |
8834461 | Werneth et al. | Sep 2014 | B2 |
8849384 | Greenspan | Sep 2014 | B2 |
8864745 | Ciavarella | Oct 2014 | B2 |
D717954 | Hjelle et al. | Nov 2014 | S |
8897516 | Turgeman | Nov 2014 | B2 |
8920411 | Gelbart et al. | Dec 2014 | B2 |
8926605 | McCarthy et al. | Jan 2015 | B2 |
8932284 | McCarthy et al. | Jan 2015 | B2 |
8961506 | McCarthy et al. | Feb 2015 | B2 |
9033893 | Spector | May 2015 | B2 |
9044245 | Condie et al. | Jun 2015 | B2 |
9095350 | Condie et al. | Aug 2015 | B2 |
9101333 | Schwartz | Aug 2015 | B2 |
9107599 | Harlev et al. | Aug 2015 | B2 |
9119633 | Gelbart et al. | Sep 2015 | B2 |
9119634 | Gelbart et al. | Sep 2015 | B2 |
9179860 | Markowitz et al. | Nov 2015 | B2 |
9179972 | Olson | Nov 2015 | B2 |
9198713 | Wallace et al. | Dec 2015 | B2 |
9204935 | Hauck et al. | Dec 2015 | B2 |
9265434 | Merschon et al. | Feb 2016 | B2 |
9277872 | Harlev et al. | Mar 2016 | B2 |
9277960 | Weinkam et al. | Mar 2016 | B2 |
9282910 | Narayan et al. | Mar 2016 | B2 |
9289606 | Paul | Mar 2016 | B2 |
9332920 | Thakur et al. | May 2016 | B2 |
9398862 | Harlev et al. | Jul 2016 | B2 |
9408544 | Laughner et al. | Aug 2016 | B2 |
9433465 | Gliner et al. | Sep 2016 | B2 |
9439578 | Thakur et al. | Sep 2016 | B2 |
9456759 | Lian et al. | Oct 2016 | B2 |
9474491 | Li et al. | Oct 2016 | B2 |
9486272 | Bonyak et al. | Nov 2016 | B2 |
9504518 | Condie et al. | Nov 2016 | B2 |
9532725 | Laughner et al. | Jan 2017 | B2 |
9532828 | Condie et al. | Jan 2017 | B2 |
9554718 | Bar-Tal et al. | Jan 2017 | B2 |
9554847 | Govari et al. | Jan 2017 | B2 |
9572620 | Ryu et al. | Feb 2017 | B2 |
9579064 | Kovtun et al. | Feb 2017 | B2 |
9603651 | Ghosh | Mar 2017 | B2 |
9603661 | Gelbart et al. | Mar 2017 | B2 |
9610045 | Du et al. | Apr 2017 | B2 |
9622806 | Mihalik | Apr 2017 | B2 |
9629567 | Porath et al. | Apr 2017 | B2 |
9636032 | Thakur et al. | May 2017 | B2 |
9655535 | Narayan et al. | May 2017 | B2 |
9662033 | Severino | May 2017 | B2 |
9693699 | Spector et al. | Jul 2017 | B2 |
9730603 | Laughner et al. | Aug 2017 | B2 |
9737267 | Strom et al. | Aug 2017 | B2 |
9743854 | Stewart et al. | Aug 2017 | B2 |
9763587 | Altmann | Sep 2017 | B2 |
9763625 | Laughner et al. | Sep 2017 | B2 |
9782094 | Du et al. | Oct 2017 | B2 |
9795314 | Laughner et al. | Oct 2017 | B2 |
9814523 | Condie et al. | Nov 2017 | B2 |
9848833 | Govari et al. | Dec 2017 | B2 |
9861802 | Mickelsen | Jan 2018 | B2 |
9875578 | Zar et al. | Jan 2018 | B2 |
9895079 | Massarwa et al. | Feb 2018 | B2 |
9913589 | Scharf et al. | Mar 2018 | B2 |
9918649 | Thakur et al. | Mar 2018 | B2 |
9918788 | Paul et al. | Mar 2018 | B2 |
9940747 | Katz et al. | Apr 2018 | B2 |
9949657 | Ravuna et al. | Apr 2018 | B2 |
9955889 | Urman et al. | May 2018 | B2 |
9980653 | Lichtenstein et al. | May 2018 | B2 |
9987083 | Gelbart et al. | Jun 2018 | B2 |
9987084 | Gelbart et al. | Jun 2018 | B2 |
10004413 | Bokan et al. | Jun 2018 | B2 |
10010368 | Laske et al. | Jul 2018 | B2 |
10016145 | Thakur et al. | Jul 2018 | B2 |
10028783 | Gelbart et al. | Jul 2018 | B2 |
10064678 | Corvi et al. | Sep 2018 | B2 |
10085659 | Laughner et al. | Oct 2018 | B2 |
20010003158 | Kensey et al. | Jun 2001 | A1 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20010018611 | Solem et al. | Aug 2001 | A1 |
20010020126 | Swanson et al. | Sep 2001 | A1 |
20010021867 | Kordis et al. | Sep 2001 | A1 |
20020002329 | Avitall | Jan 2002 | A1 |
20020016628 | Langberg et al. | Feb 2002 | A1 |
20020087156 | Maguire et al. | Jul 2002 | A1 |
20020087157 | Sliwa, Jr. et al. | Jul 2002 | A1 |
20020087173 | Alferness et al. | Jul 2002 | A1 |
20020099415 | Panescu et al. | Jul 2002 | A1 |
20020107478 | Wendlandt | Aug 2002 | A1 |
20020107511 | Collins et al. | Aug 2002 | A1 |
20020107530 | Saucer et al. | Aug 2002 | A1 |
20020115941 | Whayne et al. | Aug 2002 | A1 |
20020115944 | Mendes et al. | Aug 2002 | A1 |
20020165535 | Lesh et al. | Nov 2002 | A1 |
20020169445 | Jain et al. | Nov 2002 | A1 |
20020169504 | Alferness et al. | Nov 2002 | A1 |
20020177782 | Penner | Nov 2002 | A1 |
20020183836 | Liddicoat et al. | Dec 2002 | A1 |
20020183841 | Cohn et al. | Dec 2002 | A1 |
20020188170 | Santamore et al. | Dec 2002 | A1 |
20030028118 | Dupree et al. | Feb 2003 | A1 |
20030028183 | Sanchez et al. | Feb 2003 | A1 |
20030050637 | Maguire et al. | Mar 2003 | A1 |
20030050685 | Nikolic et al. | Mar 2003 | A1 |
20030055420 | Kadhiresan et al. | Mar 2003 | A1 |
20030060820 | Maguire et al. | Mar 2003 | A1 |
20030069570 | Witzel et al. | Apr 2003 | A1 |
20030069636 | Solem et al. | Apr 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078494 | Panescu et al. | Apr 2003 | A1 |
20030078509 | Panescu | Apr 2003 | A1 |
20030078671 | Lesniak et al. | Apr 2003 | A1 |
20030105384 | Sharkey et al. | Jun 2003 | A1 |
20030105520 | Alferness et al. | Jun 2003 | A1 |
20030109770 | Sharkey et al. | Jun 2003 | A1 |
20030125726 | Maguire et al. | Jul 2003 | A1 |
20030176810 | Maahs et al. | Sep 2003 | A1 |
20030181819 | Desai | Sep 2003 | A1 |
20030229395 | Cox | Dec 2003 | A1 |
20040002626 | Feld et al. | Jan 2004 | A1 |
20040006337 | Nasab et al. | Jan 2004 | A1 |
20040054279 | Hanley | Mar 2004 | A1 |
20040082915 | Kadan | Apr 2004 | A1 |
20040133220 | Lashinski et al. | Jul 2004 | A1 |
20040133273 | Cox | Jul 2004 | A1 |
20040138744 | Lashinski et al. | Jul 2004 | A1 |
20040153146 | Lashinski et al. | Aug 2004 | A1 |
20040158321 | Reuter et al. | Aug 2004 | A1 |
20040176797 | Opolski | Sep 2004 | A1 |
20040181139 | Falwell et al. | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040193103 | Kumar | Sep 2004 | A1 |
20040215232 | Belhe et al. | Oct 2004 | A1 |
20040243170 | Suresh et al. | Dec 2004 | A1 |
20040249408 | Murphy et al. | Dec 2004 | A1 |
20040249453 | Cartledge et al. | Dec 2004 | A1 |
20040267358 | Reitan | Dec 2004 | A1 |
20050004668 | Aklog et al. | Jan 2005 | A1 |
20050010206 | Nasab et al. | Jan 2005 | A1 |
20050015109 | Lichtenstein | Jan 2005 | A1 |
20050054938 | Wehman et al. | Mar 2005 | A1 |
20050055089 | Macoviak et al. | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050064665 | Han | Mar 2005 | A1 |
20050065420 | Collins et al. | Mar 2005 | A1 |
20050065504 | Melsky et al. | Mar 2005 | A1 |
20050080402 | Santamore et al. | Apr 2005 | A1 |
20050096047 | Haberman et al. | May 2005 | A1 |
20050096647 | Steinke et al. | May 2005 | A1 |
20050107723 | Wehman et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050125030 | Forsberg et al. | Jun 2005 | A1 |
20050148892 | Desai | Jul 2005 | A1 |
20050149014 | Hauck et al. | Jul 2005 | A1 |
20050149159 | Andreas et al. | Jul 2005 | A1 |
20050154252 | Sharkey et al. | Jul 2005 | A1 |
20050165388 | Bhola | Jul 2005 | A1 |
20050182365 | Hennemann et al. | Aug 2005 | A1 |
20050187491 | Burbank | Aug 2005 | A1 |
20050187620 | Pai et al. | Aug 2005 | A1 |
20050197593 | Burbank et al. | Sep 2005 | A1 |
20050197692 | Pai et al. | Sep 2005 | A1 |
20050197693 | Pai et al. | Sep 2005 | A1 |
20050197694 | Pai et al. | Sep 2005 | A1 |
20050203558 | Maschke | Sep 2005 | A1 |
20050209636 | Widomski et al. | Sep 2005 | A1 |
20050216054 | Widomski et al. | Sep 2005 | A1 |
20050240249 | Tu et al. | Oct 2005 | A1 |
20050245892 | Elkins | Nov 2005 | A1 |
20050251116 | Steinke et al. | Nov 2005 | A1 |
20050251132 | Oral et al. | Nov 2005 | A1 |
20050256521 | Kozel | Nov 2005 | A1 |
20050261580 | Willis et al. | Nov 2005 | A1 |
20050267458 | Paul et al. | Dec 2005 | A1 |
20050267463 | Vanney | Dec 2005 | A1 |
20050267574 | Cohn et al. | Dec 2005 | A1 |
20060009755 | Sra | Jan 2006 | A1 |
20060009756 | Francischelli et al. | Jan 2006 | A1 |
20060014998 | Sharkey et al. | Jan 2006 | A1 |
20060015002 | Moaddeb et al. | Jan 2006 | A1 |
20060015003 | Moaddes et al. | Jan 2006 | A1 |
20060015038 | Weymarn-Scharli | Jan 2006 | A1 |
20060015096 | Hauck et al. | Jan 2006 | A1 |
20060025800 | Suresh | Feb 2006 | A1 |
20060030881 | Sharkey et al. | Feb 2006 | A1 |
20060084966 | Maguire et al. | Apr 2006 | A1 |
20060085049 | Cory et al. | Apr 2006 | A1 |
20060089637 | Werneth et al. | Apr 2006 | A1 |
20060100618 | Chan et al. | May 2006 | A1 |
20060106298 | Ahmed et al. | May 2006 | A1 |
20060135968 | Schaller | Jun 2006 | A1 |
20060135970 | Schaller | Jun 2006 | A1 |
20060173251 | Govari et al. | Aug 2006 | A1 |
20060184242 | Lichtenstein | Aug 2006 | A1 |
20060199995 | Vijay | Sep 2006 | A1 |
20060229491 | Sharkey et al. | Oct 2006 | A1 |
20060235286 | Stone et al. | Oct 2006 | A1 |
20060235314 | Migliuolo et al. | Oct 2006 | A1 |
20060264980 | Khairkhahan et al. | Nov 2006 | A1 |
20060281965 | Khairkhahan et al. | Dec 2006 | A1 |
20060293698 | Douk | Dec 2006 | A1 |
20060293725 | Rubinsky et al. | Dec 2006 | A1 |
20070016068 | Grunwald et al. | Jan 2007 | A1 |
20070027533 | Douk | Feb 2007 | A1 |
20070038208 | Kefer | Feb 2007 | A1 |
20070083168 | Whiting | Apr 2007 | A1 |
20070083193 | Werneth et al. | Apr 2007 | A1 |
20070083195 | Werneth et al. | Apr 2007 | A1 |
20070088362 | Bonutti et al. | Apr 2007 | A1 |
20070115390 | Makara et al. | May 2007 | A1 |
20070118215 | Moaddeb | May 2007 | A1 |
20070129717 | Brown, III et al. | Jun 2007 | A1 |
20070161846 | Nikolic et al. | Jul 2007 | A1 |
20070198058 | Gelbart et al. | Aug 2007 | A1 |
20070213578 | Khairkhahan et al. | Sep 2007 | A1 |
20070213815 | Khairkhahan et al. | Sep 2007 | A1 |
20070232858 | Macnamara et al. | Oct 2007 | A1 |
20070249999 | Sklar et al. | Oct 2007 | A1 |
20070270688 | Gelbart et al. | Nov 2007 | A1 |
20070299343 | Waters | Dec 2007 | A1 |
20080004534 | Gelbart et al. | Jan 2008 | A1 |
20080004643 | To et al. | Jan 2008 | A1 |
20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
20080045778 | Lichtenstein et al. | Feb 2008 | A1 |
20080071298 | Khairkhahan et al. | Mar 2008 | A1 |
20080172048 | Martin et al. | Jul 2008 | A1 |
20080262337 | Falwell et al. | Oct 2008 | A1 |
20080281322 | Sherman et al. | Nov 2008 | A1 |
20080312713 | Wilfley et al. | Dec 2008 | A1 |
20090018617 | Skelton et al. | Jan 2009 | A1 |
20090024138 | Saleh | Jan 2009 | A1 |
20090069704 | MacAdam et al. | Mar 2009 | A1 |
20090131930 | Gelbart et al. | May 2009 | A1 |
20090157058 | Ferren et al. | Jun 2009 | A1 |
20090171274 | Harlev et al. | Jul 2009 | A1 |
20090182325 | Werneth et al. | Jul 2009 | A1 |
20090182405 | Arnault De La Menardiere | Jul 2009 | A1 |
20090192441 | Gelbart et al. | Jul 2009 | A1 |
20090253976 | Harlev et al. | Oct 2009 | A1 |
20090270737 | Thornton | Oct 2009 | A1 |
20090287271 | Blum et al. | Nov 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20100016762 | Thapliyal et al. | Jan 2010 | A1 |
20100023004 | Francischelli et al. | Jan 2010 | A1 |
20100113928 | Thapliyal et al. | May 2010 | A1 |
20100113985 | Thapliyal et al. | May 2010 | A1 |
20100121147 | Oskin et al. | May 2010 | A1 |
20100204560 | Salahieh | Aug 2010 | A1 |
20100211052 | Brown et al. | Aug 2010 | A1 |
20100249771 | Pearson et al. | Sep 2010 | A1 |
20100268059 | Ryu et al. | Oct 2010 | A1 |
20100286551 | Harlev et al. | Nov 2010 | A1 |
20110034912 | De Graff et al. | Feb 2011 | A1 |
20110125172 | Gelbart et al. | May 2011 | A1 |
20110172658 | Gelbart et al. | Jul 2011 | A1 |
20110213231 | Hall et al. | Sep 2011 | A1 |
20110282491 | Prisco et al. | Nov 2011 | A1 |
20120071870 | Salahieh | Mar 2012 | A1 |
20120078076 | Stewart et al. | Mar 2012 | A1 |
20120136346 | Condie et al. | May 2012 | A1 |
20120136348 | Condie et al. | May 2012 | A1 |
20120158016 | Gelbart et al. | Jun 2012 | A1 |
20120165829 | Chen et al. | Jun 2012 | A1 |
20120172859 | Condie et al. | Jul 2012 | A1 |
20120172867 | Ryu et al. | Jul 2012 | A1 |
20120271135 | Burke et al. | Oct 2012 | A1 |
20120277567 | Harlev et al. | Nov 2012 | A1 |
20130066220 | Weinkam et al. | Mar 2013 | A1 |
20130165916 | Mathur et al. | Jun 2013 | A1 |
20130172883 | Lopes et al. | Jul 2013 | A1 |
20130178850 | Lopes et al. | Jul 2013 | A1 |
20130178851 | Lopes et al. | Jul 2013 | A1 |
20130184705 | Gelbart et al. | Jul 2013 | A1 |
20130184706 | Gelbart et al. | Jul 2013 | A1 |
20130190587 | Lopes et al. | Jul 2013 | A1 |
20130190741 | Moll et al. | Jul 2013 | A1 |
20130197513 | Lopes et al. | Aug 2013 | A1 |
20130241929 | Massarwa et al. | Sep 2013 | A1 |
20130274562 | Ghaffari et al. | Oct 2013 | A1 |
20130296679 | Condie et al. | Nov 2013 | A1 |
20130296850 | Olson | Nov 2013 | A1 |
20130304065 | Lopes et al. | Nov 2013 | A1 |
20130310828 | Reinders et al. | Nov 2013 | A1 |
20130345538 | Harlev et al. | Dec 2013 | A1 |
20140114307 | Moisa et al. | Apr 2014 | A1 |
20140121659 | Paul et al. | May 2014 | A1 |
20140213894 | Gelbart et al. | Jul 2014 | A1 |
20140296850 | Condie et al. | Oct 2014 | A1 |
20140303610 | McCarthy et al. | Oct 2014 | A1 |
20140303614 | McCarthy et al. | Oct 2014 | A1 |
20140350552 | Highsmith | Nov 2014 | A1 |
20140364848 | Heimbecher et al. | Dec 2014 | A1 |
20150045660 | Gelbart et al. | Feb 2015 | A1 |
20150105701 | Mayer et al. | Apr 2015 | A1 |
20150126993 | Gelbart et al. | May 2015 | A1 |
20150157400 | Gelbart et al. | Jun 2015 | A1 |
20150182740 | Mickelsen | Jul 2015 | A1 |
20150245798 | Gelbart et al. | Sep 2015 | A1 |
20150250539 | Gelbart et al. | Sep 2015 | A1 |
20150351837 | Gelbart et al. | Dec 2015 | A1 |
20150366508 | Chou et al. | Dec 2015 | A1 |
20160008061 | Fung et al. | Jan 2016 | A1 |
20160058505 | Condie et al. | Mar 2016 | A1 |
20160106498 | Highsmith | Apr 2016 | A1 |
20160287137 | Condie et al. | Oct 2016 | A1 |
20160346030 | Thapliyal et al. | Dec 2016 | A1 |
20160361111 | Seidel | Dec 2016 | A1 |
20160367315 | Moisa et al. | Dec 2016 | A1 |
20170020604 | Lopes et al. | Jan 2017 | A1 |
20170035486 | Lopes et al. | Feb 2017 | A1 |
20170035499 | Stewart et al. | Feb 2017 | A1 |
20170065339 | Mickelsen | Mar 2017 | A1 |
20170065340 | Long | Mar 2017 | A1 |
20170079712 | Levin et al. | Mar 2017 | A1 |
20170092013 | Perlman et al. | Mar 2017 | A1 |
20170103570 | Zar et al. | Apr 2017 | A1 |
20170105627 | Katz et al. | Apr 2017 | A1 |
20170119453 | Ryu et al. | May 2017 | A1 |
20170143414 | Sliwa et al. | May 2017 | A1 |
20170156792 | Ziv-Ari et al. | Jun 2017 | A1 |
20170202470 | Urman et al. | Jul 2017 | A1 |
20170202516 | Bar-Tal et al. | Jul 2017 | A1 |
20170202521 | Urman et al. | Jul 2017 | A1 |
20170312012 | Harlev et al. | Nov 2017 | A1 |
20170333124 | Gelbart et al. | Nov 2017 | A1 |
20180036074 | Gelbart et al. | Feb 2018 | A1 |
20180036075 | Gelbart et al. | Feb 2018 | A1 |
20180036076 | Gelbart et al. | Feb 2018 | A1 |
20180036077 | Gelbart et al. | Feb 2018 | A1 |
20180042671 | Gelbart et al. | Feb 2018 | A1 |
20180042674 | Mickelsen | Feb 2018 | A1 |
20180042675 | Long | Feb 2018 | A1 |
20180055565 | Gelbart et al. | Mar 2018 | A1 |
20180056074 | Clark et al. | Mar 2018 | A1 |
20180064488 | Long et al. | Mar 2018 | A1 |
20180068439 | Hareland | Mar 2018 | A1 |
20180093088 | Mickelsen | Apr 2018 | A1 |
20180110561 | Levin et al. | Apr 2018 | A1 |
20180125575 | Schwartz et al. | May 2018 | A1 |
20180158238 | Cohen et al. | Jun 2018 | A1 |
20180160978 | Cohen et al. | Jun 2018 | A1 |
20180161097 | Zoabi et al. | Jun 2018 | A1 |
20180177467 | Katz et al. | Jun 2018 | A1 |
20180177552 | Zoabi et al. | Jun 2018 | A1 |
20180182157 | Zar et al. | Jun 2018 | A1 |
20180182159 | Cohen et al. | Jun 2018 | A1 |
20180190009 | Cohen et al. | Jul 2018 | A1 |
20180199976 | Fischer | Jul 2018 | A1 |
20180199990 | Monir et al. | Jul 2018 | A1 |
20180200497 | Mickelsen | Jul 2018 | A1 |
20180206920 | Pappone et al. | Jul 2018 | A1 |
20180214202 | Howard et al. | Aug 2018 | A1 |
20180242868 | Cohen et al. | Aug 2018 | A1 |
20180256055 | Zigelman et al. | Sep 2018 | A1 |
20180296114 | Welsh et al. | Oct 2018 | A1 |
20180325597 | Schwartz et al. | Nov 2018 | A1 |
20190046265 | Moisa et al. | Feb 2019 | A1 |
20200375659 | Gelbart | Dec 2020 | A1 |
20210000537 | Gelbart | Jan 2021 | A1 |
20210059750 | Gelbart | Mar 2021 | A1 |
Number | Date | Country |
---|---|---|
101797181 | Aug 2010 | CN |
102010026210 | Jan 2012 | DE |
102011085720 | May 2013 | DE |
0723467 | Jul 1996 | EP |
1169976 | Jan 2002 | EP |
1240868 | Sep 2002 | EP |
1182980 | Jun 2006 | EP |
1280467 | Nov 2008 | EP |
1451595 | Jul 2009 | EP |
1909679 | Nov 2013 | EP |
2307098 | Mar 2015 | EP |
2848191 | Mar 2015 | EP |
2873365 | May 2015 | EP |
2984986 | Feb 2016 | EP |
2645953 | Aug 2016 | EP |
2661236 | Aug 2016 | EP |
2749213 | Sep 2016 | EP |
2604211 | Oct 2016 | EP |
3130285 | Feb 2017 | EP |
3141185 | Mar 2017 | EP |
2689722 | Jun 2017 | EP |
2613723 | Oct 2017 | EP |
3225161 | Oct 2017 | EP |
2892454 | Jan 2018 | EP |
3318211 | May 2018 | EP |
3321890 | May 2018 | EP |
3139997 | Sep 2018 | EP |
3375365 | Sep 2018 | EP |
9510320 | Apr 1995 | WO |
9520349 | Aug 1995 | WO |
9717892 | May 1997 | WO |
0108575 | Feb 2001 | WO |
02087437 | Nov 2002 | WO |
03015611 | Feb 2003 | WO |
03077800 | Sep 2003 | WO |
2004012629 | Feb 2004 | WO |
2004047679 | Jun 2004 | WO |
2004084746 | Oct 2004 | WO |
2004100803 | Nov 2004 | WO |
2005070330 | Aug 2005 | WO |
2005102181 | Nov 2005 | WO |
2006017809 | Feb 2006 | WO |
2006105121 | Oct 2006 | WO |
2006135747 | Dec 2006 | WO |
2006135749 | Dec 2006 | WO |
2007021647 | Feb 2007 | WO |
2007115390 | Oct 2007 | WO |
2008002606 | Jan 2008 | WO |
2009011721 | Jan 2009 | WO |
2009065042 | May 2009 | WO |
2012050877 | Apr 2012 | WO |
2012100184 | Jul 2012 | WO |
2012100185 | Jul 2012 | WO |
2013064576 | May 2013 | WO |
2013173917 | Nov 2013 | WO |
2016181317 | Nov 2016 | WO |
2016181318 | Nov 2016 | WO |
2016183468 | Nov 2016 | WO |
2017009165 | Jan 2017 | WO |
2017024123 | Feb 2017 | WO |
2017087740 | May 2017 | WO |
2017120169 | Jul 2017 | WO |
2017192480 | Nov 2017 | WO |
2017192495 | Nov 2017 | WO |
2017192510 | Nov 2017 | WO |
2017192542 | Nov 2017 | WO |
2018023132 | Feb 2018 | WO |
2018165425 | Sep 2018 | WO |
Entry |
---|
Office Action issued in Chinese Application No. 201510432392.3 dated May 18, 2018. Concise Explanation of Relevance provided. |
Amendment filed in U.S. Appl. No. 14/564,463 dated Oct. 17, 2017. |
Notice of Allowance issued in U.S. Appl. No. 14/713,114 dated Nov. 1, 2017. |
Notice of Allowance issued in U.S. Appl. No. 14/564,463 dated Nov. 9, 2017. |
Preliminary Amendment filed in U.S. Appl. No. 15/784,555 dated Nov. 7, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/784,775 dated Nov. 7, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/784,722 dated Nov. 7, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/725,731 dated Oct. 24, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/784,647 dated Nov. 7, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/725,662 dated Oct. 24, 2017. |
Office Action issued in U.S. Appl. No. 14/804,924 dated Nov. 17, 2017. |
Response to Office Action filed in U.S. Appl. No. 13/785,910 dated Nov. 30, 2017. |
Amendment filed in U.S. Appl. No. 13/785,910 dated Feb. 27, 2018. |
Examination Report issued in European Application No. 13793216.6 dated Nov. 24, 2017. |
Office Action issued in Chinese Application No. 201510432392.3 dated Nov. 17, 2017. Concise Explanation of Relevance and English translation provided. |
Examination Report issued in European Application No. 15188407.9 dated Dec. 11, 2017. |
Office Action issued in U.S. Appl. No. 13/785,910 dated Jan. 12, 2018. |
Amendment filed in U.S. Appl. No. 14/804,924 dated Feb. 27, 2018. |
Office Action issued in U.S. Appl. No. 14/804,810 dated Nov. 30, 2017. |
Amendment filed in U.S. Appl. No. 14/804,810 dated Feb. 27, 2018. |
Notice of Allowance issued in U.S. Appl. No. 14/804,924 dated Mar. 27, 2018. |
Notice of Allowance issued in U.S. Appl. No. 14/804,810 dated Mar. 30, 2018. |
Office Action issued in copending U.S. Appl. No. 16/658,820 dated Oct. 22, 2021. |
Copending U.S. Appl. No. 17/513,070, filed Oct. 28, 2021. |
Office Action issued in copending U.S. Appl. No. 16/662,537 dated Oct. 29, 2021. |
Amendment filed in copending U.S. Appl. No. 16/521,712 dated Nov. 1, 2021. |
Preliminary Amendment filed in copending U.S. Appl. No. 17/513,070 dated Nov. 8, 2021. |
Office Action issued in copending U.S. Appl. No. 15/299,640 dated Nov. 12, 2021. |
Notice of Allowance issued in copending U.S. Appl. No. 15/287,988 dated Nov. 15, 2021. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/369,528 dated Apr. 24, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/381,344 dated Apr. 24, 2019. |
Copending U.S. Appl. No. 16/407,379, filed May 9, 2019. |
Office Action issued in copending U.S. Appl. No. 15/254,130 dated May 28, 2019. |
Examination Report issued in Indian Application No. 9902/DELNP/2014 dated Jun. 19, 2020. English translation provided. |
Office Action issued in copending U.S. Appl. No. 15/697,744 dated Jul. 8, 2020. |
Amendment and Statement on the Substance of the Interview filed in copending U.S. Appl. No. 15/784,722 dated Jul. 9, 2020. |
Amendment and Statement on the Substance of the Interview filed in copending U.S. Appl. No. 15/784,775 dated Jul. 9, 2020. |
Amendment filed in copending U.S. Appl. No. 15/784,555 dated Jun. 3, 2020. |
Notice of Allowance issued in copending U.S. Appl. No. 15/784,647 dated Jul. 23, 2020. |
Notice of Intention to Grant issued in European Application No. 14871405.8 dated Jan. 22, 2019. |
Notice of Intention to Grant issued in European Application No. 15188407.9 dated Mar. 20, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/697,744 dated Sep. 21, 2017. |
Copending U.S. Appl. No. 16/369,528, filed Mar. 29, 2019. |
Extended European Search Report issued in European Application No. 19215957.2 dated Mar. 26, 2020. |
Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,636 dated Jul. 22, 2016, 5 pgs. |
Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,636 dated Nov. 17, 2016, 3 pgs. |
Lopes et al., “High-Density Electrode-Based Medical Device System”, Preliminary Amendment filed in U.S. Appl. No. 15/287,988 dated Nov. 23, 2016, 9 pgs. |
Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,621 dated Jul. 22, 2016, 5 pgs. |
Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,621 dated Nov. 17, 2016, 3 pgs. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed in U.S. Appl. No. 13/782,889 dated May 17, 2016, 51 pgs. |
Lopes et al., “High-Density Electrode-Based Medical Device System” Amendment filed in U.S. Appl. No. 13/793,213 dated May 26, 2016, 39 pgs. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed in U.S. Appl. No. 13/782,867 dated May 17, 2016, 39 pgs. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method”, Amendment filed in U.S. Appl. No. 11/475,950 dated Feb. 12, 2013, 4 pgs. |
Moisa et al., “Catheter System”, Preliminary Amendment filed in copending U.S. Appl. No. 15/254,130 dated Sep. 19, 2016, 22 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment filed in U.S. Appl. No. 14/804,924 dated Jul. 30, 2015, 5 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment filed in U.S. Appl. No. 14/804,810 dated Jul. 30, 2015, 10 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed in U.S. Appl. No. 14/713,190 dated May 15, 2015, 3 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed in U.S. Appl. No. 14/713,190 dated Jun. 16, 2015, 7 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed in U.S. Appl. No. 14/713,114 dated Jun. 16, 2015, 8 pgs. |
Office Action issued in U.S. Appl. No. 14/521,692 dated Jan. 10, 2017. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed in U.S. Appl. No. 14/229,305 dated Sep. 27, 2016, 15 pgs. |
Notice of Allowance issued in U.S. Appl. No. 14/229,305 dated Nov. 8, 2016. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed in U.S. Appl. No. 14/229,250 dated Sep. 27, 2016, 13 pgs. |
Notice of Allowance issued in U.S. Appl. No. 14/229,250 dated Dec. 7, 2016. |
Moisa et al., “Catheter System”, Amendment filed in U.S. Appl. No. 14/136,946 dated Apr. 18, 2016, 19 pgs. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed in U.S. Appl. No. 13/942,354 dated Jan. 4, 2017, 23 pgs. |
Lopes et al., “High-Density Electrode-Based Medical Device System”, Preliminary Amendment filed in U.S. Appl. No. 13/793,076 dated May 26, 2016, 15 pgs. |
Lopes et al., “High-Density Electrode-Based Medical Device System”, Amendment filed in U.S. Appl. No. 13/793,076 dated May 9, 2016, 15 pgs. |
Gelbart et al., “Apparatus and Method for Intracardiac Mapping and Ablation”, Preliminary Amendment filed in U.S. Appl. No. 13/785,931 dated Mar. 5, 2013, 2 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in U.S. Appl. No. 13/785,910 dated Feb. 9, 2016, 11 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in U.S. Appl. No. 13/785,910 dated Jan. 5, 2016, 15 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in U.S. Appl. No. 13/785,910 dated Aug. 8, 2016, 18 pgs. |
Office Action issued in U.S. Appl. No. 13/785,910 dated Nov. 2, 2016. |
Buchbinder,Maurice MD, “Dynamic Mitral Valve Annuloplasty: A Reshapable Ring for Residual and Recurring MR,” from the Foundation for Cardiovascular Medicine, La Jolla, CA. May 24, 2007. |
Gabriel et al., “The Dielectric Properties of Biological Tissues: I. Literature Survey,” Phys. Med. Biol. 41:2231-2249, 1996. |
Konings et al., “Development of an Intravascular Impedance Catheter for Detection of Fatty Lesions in Arteries,” IEEE Transactions on Medical Imaging, 16(4):439-446, 1997. |
Mack, “New Techniques for Percutaneous Repair of the Mitral Valve,” Heart Failure Review, 11:259-268, 2006. |
Otasevic et al., “First-in-Man Implantation of Left Ventricular Partitioning Device in a Patient With Chronic Heart Failure: Twelve-Month Follow-up,” Journal of Cardiac Failure 13(7):517-520, 2007. |
Sharkey et al., “Left Ventricular Apex Occluder. Description of a Ventricular Partitioning Device,” EuroIntervention 2:125-127, 2006. |
Stiles, et al., “Simulated Characterization of Atherosclerotic Lesions in the Coronary Arteries by Measurement of Bioimpedance,” IEE Transactions on Biomedical Engineering, 50(7):916-921,2003. |
Tanaka et al., “Artificial SMA Valve for Treatment of Urinary Incontinence: Upgrading of Valve and Introduction of Transcutaneous Transformer,” Bio-Medical Materials and Engineering 9:97-112, 1999. |
Timek et al.., “Septal-Lateral Annular Cinching (‘SLAC’) Reduces Mitral Annular Size Without Perturbing Normal Annular Dynamics,” Journal of Heart Valve Disease 11 (1):2-10, 2002. |
Timek et al., “Septal-Lateral Annular Cinching Abolishes Acute Ischemic Mitral Regurgitation,” Journal of Thoracic and Cardiovascular Surgery, 123(5):881-888, 2002. |
Valvano et al., “Thermal Conductivity and Diffusivity of Biomaterials Measured with Self-Heated Thermistors,” International Journal of Thermodynamics, 6(3):301-311, 1985. |
Gelbart et al., “Automatic Atherectomy System,” Office Action dated Mar. 4, 2009 for U.S. Appl. No. 11/436,584, 7 pages. |
Gelbart et al., “Automatic Atherectomy System,” Amendment dated Aug. 4, 2009 for U.S. Appl. No. 11/436,584, 35 pages. |
Gelbart et al., “Automatic Atherectomy System,” Office Action dated Dec. 1, 2009 for U.S. Appl. No. 11/436,584, 10 pages. |
Gelbart et al., “Automatic Atherectomy System,” Amendment dated Mar. 30, 2010 for U.S. Appl. No. 11/436,584, 20 pages. |
Gelbart et al., “Automatic Atherectomy System,” Amendment dated Oct. 25, 2010 for U.S. Appl. No. 11/436,584, 9 pages. |
Gelbart et al., “Automatic Atherectomy System,” Office Action dated Dec. 14, 2010 for U.S. Appl. No. 11/436,584, 12 pages. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Preliminary Amendment dated Aug. 29, 2007 for U.S. Appl. No. 11/475,950,42 pages. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Amendment dated Mar. 5, 2008 for U.S. Appl. No. 11/475,950, 11 pages. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Office Action dated Jun. 23, 2010 for U.S. Appl. No. 11/475,950, 18 pages. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Amendment dated Aug. 16, 2010 for U.S. Appl. No. 11/475,950, 22 pages. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Office Action dated Nov. 23, 2010 for U.S. Appl. No. 11/475,950, 25 pages. |
Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Amendment dated Feb. 23, 2011 for U.S. Appl. No. 11/475,950, 28 pages. |
Gelbart et al., “Automatic Atherectomy System,” Office Action dated Jun. 15, 2011, for U.S. Appl. No. 12/950,871, 16 pages. |
Gelbart et al., “Liposuction System,” Office Action dated Mar. 16, 2011 for U.S. Appl. No. 12/010,458, 12 pages. |
Gelbart et al., “Liposuction System,” Amendment dated Jun. 10, 2011 for U.S. Appl. No. 12/010,458, 10 pages. |
Lightenstein “Method and Apparatus for Percutaneous Reduction of Anterior-Posterior Diameter of Mitral Valve,” U.S. Appl. No. 10/690,131, filed Oct. 20, 2003, 31 pages. |
International Search Report, dated Dec. 5, 2007, for PCT/US2007/014902, 5 pages. |
International Preliminary Report on Patentability, dated Jan. 6, 2009, for PCT/US2007/014902, 8 pages. |
International Search Report, dated Dec. 2, 2009, for PCT/US2008/083644, 5 pages. |
Written Opinion, dated Dec. 5, 2007, for PCT/US2007/014902, 7 pages. |
Written Opinion, dated Dec. 2, 2009, for PCT/US2008/083644, 9 pages. |
Gelbart et al., “Automatic Atherectomy System,” Amendment dated Sep. 15, 2011 for U.S. Appl. No. 12/950,871, 21 pages. |
Gelbart et al., “Liposuction System,” Amendment dated Dec. 7, 2011 for U.S. Appl. No. 12/010,458, 15 pages. |
Gelbart et al., “Liposuction System,” Office Action dated Sep. 14, 2011 for U.S. Appl. No. 12/010,458, 9 pages. |
Notice of Allowance issued in U.S. Appl. No. 13/782,889, dated Aug. 25, 2016. |
Office Action issued in copending U.S. Appl. No. 15/725,662 dated May 13, 2020. |
Office Action issued in copending U.S. Appl. No. 15/725,731 dated May 15, 2020. |
Amendment filed in copending U.S. Appl. No. 15/784,647 dated May 27, 2020. |
Amendment filed in copending U.S. Appl. No. 15/697,744 dated May 27, 2020. |
Extended European Search Report issued in European Application No. 19189222.3 dated Nov. 29, 2019. |
Office Action issued in Chinese Application No. 201810941271.5 dated Jun. 3, 2021. English language Statement of Relevance provided. |
Amendment filed in copending U.S. Appl. No. 15/287,988 dated Jul. 28, 2021. |
Non-Final Office Action issued in copending U.S. Appl. No. 16/521,712 dated Sep. 30, 2021. |
Copepending U.S. Appl. No. 17/500,186, filed Oct. 13, 2021. |
Preliminary Amendment filed in copending U.S. Appl. No. 17/500,186 dated Oct. 19, 2021. |
Examination Report issued in European Appln. No. 14871405.8 dated Jul. 6, 2018. |
Office Action issued in U.S. Appl. No. 13/785,910 dated Jun. 15, 2018. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/407,379 dated Jun. 12, 2019. |
Notice of Intention to Grant issued in EP Appln. No. 13793216.6 dated Jul. 15, 2019. |
Copending U.S. Appl. No. 16/521,712, filed Jul. 25, 2019. |
Copending U.S. Appl. No. 16/521,732, filed Jul. 25, 2019. |
Copending U.S. Appl. No. 16/521,745, filed Jul. 25, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/521,712 dated Jul. 25, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/521,732 dated Jul. 25, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/521,745 dated Jul. 25, 2019. |
Amendment filed in copending U.S. Appl. No. 15/254,130 dated Aug. 13, 2019. |
Second Preliminary Amendment filed in copending U.S. Appl. No. 16/521,712 dated Aug. 15, 2019. |
Second Preliminary Amendment filed in copending U.S. Appl. No. 16/521,732 dated Aug. 15, 2019. |
Second Preliminary Amendment filed in copending U.S. Appl. No. 16/521,745 dated Aug. 15, 2019. |
Becker R. et al., “Ablation of Atrial Fibrillation: Energy Sources and Navigation Tools: A Review”, Journal of Electrocardiology, 37 (Supplement 2004): 55-62, 2004. |
Calkins, Hugh, “Radiofrequency Catheter Ablation of Supraventricular Arrhythmias”, Heart, 85:594-600, 2001. |
De Ponti et al., “Non-Fluoroscopic Mapping Systems for Electrophysiology: The ‘Tool or Toy’ Dilemma After 10 Years”,European Heart Journal 27:1134-1136, 2006. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Office Action dated Dec. 13, 2013; Notice of Allowance dated Jul. 25, 2014 for U.S. Appl. No. 11/475,950, 19 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Office Action dated Jan. 3, 2012; Office Action dated Apr. 3, 2014; Notice of Allowance dated Aug. 26, 2014 for U.S. Appl. No. 11/941,819, 35 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed Apr. 10, 2014 Supplemental Amendment dated Feb. 12, 2013 for U.S. Appl. No. 11/475,950, 21 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment dated Aug. 22, 2014; Preliminary Amendment dated Mar. 5, 2013 for U.S. Appl. No. 13/785,910, 10 pgs. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment dated Aug. 22, 2014; Preliminary Amendment dated Mar. 5, 2013 for U.S. Appl. No. 13/785,931, 10 pgs. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Preliminary Amendment dated Oct. 22, 2013 for U.S. Appl. No. 13/942,354, 13 pgs. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Preliminary Amendment dated Aug. 20, 2014 for U.S. Appl. No. 13/782,889, 11 pgs. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Preliminary Amendment dated Mar. 14, 2013 for U.S. Appl. No. 13/782,867, 8 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment dated Jul. 3, 2014; Amendment dated Apr. 2, 2012; Amendment dated Mar. 1, 2012; Amendment dated Nov. 23, 2011; Replacement drawings filed Feb. 13, 2008 for U.S. Appl. No. 11/941,819, 78 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment dated May 12, 2014; Preliminary Amendment dated May 2, 2014 for U.S. Appl. No. 14/229,305, 12 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed May 12, 2014; Preliminary Amendment filed May 2, 2014 for U.S. Appl. No. 14/229,250, 10 pgs. |
Gelbart et al., Medical Device for Use in Bodily Lumens, for Example an Atrium, Amendment dated Sep. 22, 2014, for U.S. Appl. No. 13/070,215, 18 pgs. |
Gelbart et al., Medical Device for Use in Bodily Lumens, for Example an Atrium, Office Action dated Jun. 20, 2014, for U.S. Appl. No. 13/070,215, 8 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Supplemental Notice of Allowance dated Oct. 6, 2014 for U.S. Appl. No. 11/941,819, 4 pgs. |
Notice of Allowance issued in U.S. Appl. No. 13/793,213 dated Aug. 10, 2016. |
Non-Final Office Action issued in U.S. Appl. No. 13/942,354 dated Aug. 4, 2016. |
Notice of Allowance issued in U.S. Appl. No. 14/136,946 dated May 12, 2016. |
Notice of Allowance issued in U.S. Appl. No. 13/782,867 dated Aug. 12, 2016. |
Notice of Allowance issued in U.S. Appl. No. 13/782,903 dated Jul. 6, 2016. |
Corrected Notice of Allowance issued in U.S. Appl. No. 13/782,903 dated Jul. 19, 2016. |
Non-Final Office Action issued in U.S. Appl. No. 14/229,305, dated Apr. 29, 2016. |
Notice of Allowance issued in U.S. Appl. No. 29/509,621, dated Sep. 27, 2016. |
Notice of Allowance issued in U.S. Appl. No. 29/509,636, dated Sep. 27, 2016. |
Extended European Search Report issued in European Appln. No. 19172980.5 dated Aug. 21, 2019. |
Notice of Allowance issued in copending U.S. Appl. No. 15/254,130 dated Sep. 12, 2019. |
Notice of Allowance issued in copending U.S. Appl. No. 15/663,077 dated Sep. 24, 2019. |
Office Action issued in German Patent Appln No. 112008003108.8 dated Oct. 28, 2019. English machine translation provided. |
Codepending U.S. Appl. No. 16/655,775, filed Oct. 17, 2019. |
Codepending U.S. Appl. No. 16/658,820, filed Oct. 21, 2019. |
Coepending U.S. Appl. No. 16/662,537, filed Oct. 24, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/655,775 dated Nov. 1, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/658,820 dated Nov. 7, 2019. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/662,537 dated Nov. 19, 2019. |
Office Action issued in copending U.S. Appl. No. 15/784,722 dated Mar. 23, 2020. |
Office Action issued in copending U.S. Appl. No. 15/784,775 dated Mar. 23, 2020. |
Copending U.S. Appl. No. 16/381,344, filed Apr. 11, 2019. |
Office Action issued in U.S. Appl. No. 14/564,463 dated Feb. 28, 2017. |
Notice of Allowance issued in U.S. Appl. No. 13/942,354 dated Feb. 10, 2017. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in co-pending U.S. Appl. No. 13/785,910 dated Mar. 24, 2017, 30 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed in co-pending U.S. Appl. No. 14/521,692 dated Mar. 31, 2017, 9 pgs. |
Office Action issued in Chinese Patent Application No. 201510432392.3 dated Mar. 8, 2017. English concise Explanation of Relevance provided. |
Decision to Refuse a European Patent Application issued in European Patent Application No. 13172848.7 dated Feb. 22, 2017. |
Notice of Allowance issued in U.S. Appl. No. 14/521,692 dated May 19, 2017. |
Office Action issued in U.S. Appl. No. 14/713,114 dated Jun. 1, 2017. |
Quayle Action issued in U.S. Appl. No. 14/713,190 dated May 30, 2017. |
Office Action issued in German Application No. 112008003108.8 dated May 8, 2017. English translation provided. |
Amendment filed in U.S. Appl. No. 14/564,463 dated May 25, 2017. |
Office Action issued in U.S. Appl. No. 14/564,463 dated Jul. 17, 2017. |
European Search Report issued in European Appln. No. 14871405.8 dated Jul. 5, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/299,640 pp. 4 dated Oct. 21, 2016. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/299,640 pp. 11 dated Dec. 9, 2016. |
Response to Quayle Office Action filed in U.S. Appl. No. 14/713,190, dated Jul. 24, 2017. |
Preliminary Amendment filed in U.S. Appl. No. 14/521,692 dated Oct. 23, 2014. |
Office Action issued in U.S. Appl. No. 13/785,910 dated Aug. 30, 2017. |
Preliminary Amendment filed in copending U.S. Appl. No. 15/663,077, dated Aug. 8, 2017. |
Amendment filed in U.S. Appl. No. 14/713,114, dated Aug. 23, 2017. |
Notice of Allowance issued in U.S. Appl. No. 14/713,190 dated Aug. 28, 2017. |
Office Action issued in copending U.S. Appl. No. 15/697,744 dated Feb. 28, 2020. |
Office Action issued in copending U.S. Appl. No. 15/784,647 dated Feb. 28, 2020. |
Office Action issued in copending U.S. Appl. No. 15/784,555 dated Mar. 9, 2020. |
Notice of Allowance issued in copending U.S. Appl. No. 15/784,775 dated Aug. 7, 2020. |
Notice of Allowance issued in copending U.S. Appl. No. 15/784,555 dated Aug. 11, 2020. |
Amendment and Statement on the Substance of the Interview filed in copending U.S. Appl. No. 15/725,662 dated Aug. 13, 2020. |
Amendment and Statement on the Substance of the Interview filed in copending U.S. Appl. No. 15/725,731 dated Aug. 13, 2020. |
Notice of Allowance issued in copending U.S. Appl. No. 15/784,722 dated Aug. 14, 2020. |
Office Action issued in copending U.S. Appl. No. 16/407,379 dated Dec. 24, 2020. |
Amendment filed in copending U.S. Appl. No. 16/407,379 dated Mar. 23, 2021. |
Notice of Allowance issued in copending U.S. Appl. No. 15/725,662 dated Sep. 3, 2020. |
Notice of Allowance issued in copending U.S. Appl. No. 15/725,731 dated Sep. 3, 2020. |
Notice of Allowance issued in copending U.S. Appl. No. 15/697,744 dated Sep. 18, 2020. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/995,159 dated Sep. 25, 2020. |
Preliminary Amendment filed in copending U.S. Appl. No. 16/995,222 dated Sep. 25, 2020. |
Preliminary Amendment filed in copending U.S. Appl. No. 17/182,732 dated Mar. 11, 2021. |
Preliminary Amendment filed in copending U.S. Appl. No. 17/072,262 dated Dec. 1, 2020. |
Office Action issued in Chinese Appln. No. 201810941271.5 dated Nov. 3, 2020. English translation provided. |
Copending U.S. Appl. No. 17/182,732, filed Feb. 23, 2021. |
Preliminary Amendment filed in copending U.S. Appl. No. 17/182,732 dated Feb. 23, 2021. |
Notice of Allowance issued in copending U.S. Appl. No. 16/407,379 dated Apr. 1, 2021. |
Bard, “Mesh Ablator Catheter”, Brochure, 2008, 4 pgs, Bard Electrophysiology Division, C.R. Bard Inc., 55 Technology Drive Lowell, MA 07851 USA. |
BIOTRONIK's “AICath Flutter Gold Cath for Atrial Flutter Available in EU”, Sep. 19, 2013, medGadget, 3 pgs, http://www.medgadget.com/2013/09/biotroniks-alcath-flutter-gold-cath-for-atrial-flutter-unveiled-in-europe.html (Jun. 24, 2014 2:37:09 PM]. |
“Constellation Mapping Catheters”, Brochure, Boston Scientific Corp., 2 pgs © 2007 Boston Scientific Corporation. |
“Waveforms and Segments”, Ensite System Instructions for use, 54-06154-001 Rev02, Chapter 7 pp. 85-90 © 2007 St. Jude Medical. |
Extended European Search Report and EP search opinion for EP 12736677.1, dated Mar. 28, 2014, corresponding to PCT/US2012/022061. |
Extended European Search Report and EP search opinion for EP 12736962.7, dated Mar. 28, 2014, corresponding to PCT/US2012/022062. |
Extended European Search Report dated Aug. 20, 2013 issued in EP Patent Application No. 13172848.7. |
Written Opinion dated Aug. 22, 2012 for PCT/US2012/022061, 6 pgs. |
International Search Report and Written Opinion dated Aug. 2, 2013 issued in PCT/CA2013/050350. |
International Search Report and Written Opinion dated Sep. 17, 2013 issued in PCT/US2013/039982. |
International Search Report and Written Opinion dated Sep. 27, 2013 issued in PCT/US2013/039977. |
International Search Report dated Jul. 30, 2012 for PCT/US2012/022062, 5 pgs. |
Written Opinion dated Jul. 30, 2012 for PCT/US2012/022062, 5 pgs. |
International Search Report dated Aug. 22, 2012 for PCT/US2012/022061, 5 pgs. |
“Phased RF Catheter Ablation System”, 2014 Medtronic Inc., 2 pgs, http://www.medtronic.eu/your-health/atrial-fibrillation/about-the-therapy/our-phased-rf-ablation-system/[Jun. 24, 2014 2:38:05 PM]. |
“ThermoCool® Irrigated Tip Catheter”, Brochure, Biosense Webster, 4 pgs , Biosense Webster, Inc. 3333 Diamond Canyon Road Diamond Bar, CA 91765, USA, ©Biosense Webster, Inc. 2009 All rights reserved. 1109003.0. |
Gelbart “Medical Device for Use in Bodily Lumens, for Example an Atrium”, OA dated Jul. 25, 2011 for U.S. Appl. No. 11/941,819, now published as US 2009-0131930 A1. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Notice of Allowance dated Oct. 23, 2014 for U.S. Appl. No. 11/475,950, 10 pgs. |
Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Notice of Allowance dated Nov. 13, 2014 for U.S. Appl. No. 13/070,215, 54 pages. |
International Search Report dated Mar. 10, 2015, for International Application PCT/CA2014/051144; 10 pages. |
Written Opinion dated Mar. 10, 2015, for International Application PCT/CA2014/051144; 4 pages. |
Official Action issued in CN201280004400.9, dated Dec. 3, 2014. |
Non-final Office Action issued in U.S. Appl. No. 13/782,867, dated Apr. 15, 2015. |
Non-Final Office Action issued in U.S. Appl. No. 13/782,903, dated Apr. 28, 2015. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Office Action dated May 22, 2015 for U.S. Appl. No. 13/782,889, 86 pages. |
Lopes et al., “High-Density Electrode-Based Medical Device System”, Office Action dated Jul. 10, 2015 for U.S. Appl. No. 13/793,076, 98 pages. |
Lopes et al., “High-Density Electrode-Based Medical Device System”, Office Action dated Jul. 9, 2015 tor U.S. Appl. No. 13/793,213, 99 pages. |
Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Office Action dated Aug. 5, 2015 for U.S. Appl. No. 13/785,910, 79 pages. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment dated Aug. 24, 2015 for U.S. Appl. No. 13/782,889, 21 pages. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment dated Aug. 28, 2015 for U.S. Appl. No. 13/782,903, 19 pages. |
Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment dated Sep. 14, 2015 for U.S. Appl. No. 13/782,867, 25 pages. |
Lopes et al., “High-Density Electrode-Based Medical Device System ”, Amendment dated Oct. 9, 2015 for U.S. Appl. No. 13/793,213, 26 pages. |
Lopes et al., “High-Density Electrode-Based Medical Device System ”, Amendment dated Oct. 9, 2015 for U.S. Appl. No. 13/793,076, 14 pages. |
Examination Report issued in EP13172848.7, dated Sep. 21, 2015. |
Extended European Search Report issued in EP13793216.6, dated Oct. 30, 2015. |
Moisa et al., “Catheter System”, Office Action dated Nov. 16, 2015 for U.S. Appl. No. 14/136,946, 92 pages. |
Office Action issued in U.S. Appl. No. 13/782,889, dated Dec. 18, 2015. |
Office Action issued in U.S. Appl. No. 13/782,903, dated Dec. 18, 2015. |
Extended European Search Report issued in EP15188407.9, dated Jan. 21, 2016. |
Lopes et al. “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Office Action dated Jan. 25, 2016 for U.S. Appl. No. 13/782,867, 49 pages. |
Notice of Allowance issued in U.S. Appl. No. 13/793,076, dated Feb. 10, 2016. |
Final Office Action issued in U.S. Appl. No. 13/793,213, dated Feb. 26, 2016. |
Non-Final Office Action issued in U.S. Appl. No. 29/509,719, dated Feb. 25, 2016. |
Quayle Action issued in U.S. Appl. No. 29/509,621, dated Feb. 26, 2016. |
Quayle Action issued in U.S. Appl. No. 29/509,636, dated Feb. 26, 2016. |
Non-Final Office Action issued in U.S. Appl. No. 13/785,910, dated Apr. 8, 2016. |
Non-Final Office Action issued in U.S. Appl. No. 14/229,250 dated Apr. 28, 2016. |
Notice of Allowance issued in U.S. Appl. No. 13/793,076 dated Jul. 7, 2016. |
Summons to Attend Oral Proceedings issued in European Appln. No. 13172848.7, dated Sep. 1, 2016. |
Response to Examination Opinion dated Mar. 18, 2021 for Chinese Patent Application No. 201810941271.5. |
Office Action issued in copending U.S. Appl. No. 15/287,988 dated May 5, 2021. |
Supplemental Amendment filed in copending U.S. Appl. No. 15/299,640 dated Mar. 1, 2022. |
Amendment filed in copending U.S. Appl. No. 16/369,528 dated Mar. 2, 2022. |
Notice of Allowance issued in copending U.S. Appl. No. 16/658,820 dated Mar. 11, 2022. |
Non-Final Office Action issued in copending U.S. Appl. No. 17/584,705 dated Mar. 29, 2022. |
Amendment filed in copending U.S. Appl. No. 16/381,344 dated Apr. 4, 2022. |
Non-Final Office Action issued in copending U.S. Appl. No. 16/369,528 dated Dec. 6, 2021. |
Notice of Allowance issued in Chinese Application No. 201810941271.5 dated Dec. 22, 2021. |
Non-Final Office Action issued in copending U.S. Appl. No. 17/500,186 dated Feb. 9, 2022. |
Notice of Allowance issued in copending U.S. Appl. No. 16/521,712 dated Jan. 11, 2022. |
Amendment filed in copending U.S. Appl. No. 16/658,820 dated Jan. 17, 2022. |
Amendment filed in copending U.S. Appl. No. 16/662,537 dated Jan. 18, 2022. |
Non-Final Office Action issued in copending U.S. Appl. No. 16/381,344 dated Feb. 1, 2022. |
Preliminary Amendment filed in copending U.S. Appl. No. 17/584,705 dated Feb. 2, 2022. |
Copending U.S. Appl. No. 17/584,705, filed Jan. 26, 2022. |
Amendment filed in copending U.S. Appl. No. 15/299,640 dated Feb. 8, 2022. |
Notice of Allowance issued in copending U.S. Appl. No. 16/662,537 dated Feb. 14, 2022. |
Notice of Allowance issued in copending U.S. Appl. No. 16/161,319 dated Feb. 16, 2022. |
Office Action issued in copending European Application No. 19172980.5 dated Jan. 21, 2022. |
Copending U.S. Appl. No. 17/716,303, filed Apr. 8, 2022. |
Amendment filed in copending U.S. Appl. No. 17/500,186 dated Apr. 28, 2022. |
Notice of Allowance issued in copending U.S. Appl. No. 16/369,528 dated May 12, 2022. |
Number | Date | Country | |
---|---|---|---|
20190307506 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15697744 | Sep 2017 | US |
Child | 16381317 | US | |
Parent | 14804810 | Jul 2015 | US |
Child | 15697744 | US | |
Parent | 13785931 | Mar 2013 | US |
Child | 14804810 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11475950 | Jun 2006 | US |
Child | 13785931 | US |